# MEI Pharma, Inc.: Form D filings

MEI Pharma, Inc., a pharmaceuticals company in San Diego, CA, filed 2 Form D notices with the SEC between 2011 and 2018. The latest, on May 30, 2018, reports $75 million sold of a $75 million offering to 20 investors.

Find out what MEI Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20MEI%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=MEI%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmei-pharma-inc-1262104)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20MEI%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=MEI%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmei-pharma-inc-1262104)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3611 Valley Centre Drive, SUITE 500, San Diego, CA, 92130
- Phone: (858) 369-7100
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1262104

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 30, 2018 | New notice | $74,999,990 | $74,999,990 | $0 | 20 | May 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1262104/000126210418000002/0001262104-18-000002-index.htm) |
| May 31, 2011 | New notice | $1,113,344 | $1,113,344 | $0 | 2 | May 16, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1262104/000126210411000002/0001262104-11-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Frederick W. Driscoll | Director |  |
| Christine A. White | Director |  |
| David M. Urso | Executive Officer |  |
| Nicholas R. Glover | Director |  |
| William D. Rueckert | Director |  |
| Daniel P. Gold | Executive Officer, Director |  |
| Kevan E. Clemens | Director |  |
| Thomas C. Reynolds | Director |  |
| Robert D. Mass | Executive Officer |  |
| Brian G. Drazba | Executive Officer |  |
| Charles V. Baltic III | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of May 28, 2018](https://specstream.ai/data/form-d/week/2018-05-28) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what MEI Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).